LUSIP: Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients

Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (Other)
Overall Status
Completed
CT.gov ID
NCT03828630
Collaborator
Mahidol Oxford Tropical Medicine Research Unit (Other), University of Sierra Leone (Other), Doctors with Africa - CUAMM (Other), University of Bari (Other)
168
1
8.6
19.4

Study Details

Study Description

Brief Summary

This study aims at describing the frequency, timing and type of pulmonary complications detected with lung ultrasound in critically-ill parturients in admitted to a high-dependency unit in Freetown, Sierra Leone.

Detailed Description

Rationale: The three big 'killers' in parturients, peripartum hemorrhage, sepsis and pre-eclampsia all predispose to pulmonary complications. These complications affect management before, during and after the primary obstetric problem has been solved. A timely diagnosis and thorough follow-up of pulmonary complications may benefit parturients. Lung ultrasound (LUS) is a point-of-care imaging bedside tool increasingly used in the critical care setting that may prove useful in parturients.

Objective: To describe frequency, timing and type of pulmonary complications detected with LUS in critically ill parturients in a high-dependency unit (HDU), and to determine the association with outcome.

Hypotheses: Pulmonary complications detected by LUS are frequent in parturients admitted to a HDU in a resource-limited setting, and are associated with hospital mortality.

Study design: A prospective observational study. Study population: Critically ill parturients admitted to the HDU of the Princess Christian Maternity Hospital (PCMH) in Freetown, Sierra Leone.

Sample size: No formal sample size calculation is performed. Based on current rates of admissions to the HDU of the PCMH the investigators expect to perform LUS in at least 125 patients.

Methods: A trained physician performs all 12-region LUS investigations. LUS is performed at admission, after 24 and 48 hours, and when a patient's respiratory condition deteriorates. LUS findings are reported using a standardized semi-quantitative visual LUS scoring method.

Main study parameters/primary endpoints: The proportion of critically ill parturients admitted to the HDU of the PCMH with pulmonary complications detected by LUS, including interstitial syndrome, pulmonary consolidation, and pleural effusion.

Study Design

Study Type:
Observational
Actual Enrollment :
168 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Lung Ultrasound to Detect Pulmonary Complications in Critically Ill Parturients in an Urban Low-Resource Setting (LUSIP) - an Observational Study in Sierra Leone
Actual Study Start Date :
Jul 8, 2018
Actual Primary Completion Date :
Feb 27, 2019
Actual Study Completion Date :
Mar 28, 2019

Outcome Measures

Primary Outcome Measures

  1. Proportion of parturients with pulmonary complications [From admission to 48 hours later]

    proportion of parturients with pulmonary complications detected by LUS during stay in the HDU.

Secondary Outcome Measures

  1. Description of lung ultrasound findings [From admission to 48 hours later]

    Precise description of ultrasound findings (proportion of patients with a normal lung, interstitial syndrome, lung consolidation, pleural effusion)

  2. Description of diagnoses made with lung ultrasound [From admission to 48 hours later]

    Proportion of patients with a diagnosis of pneumonia, acute respiratory distress syndrome, fluid overload, no pulmonary complication.

  3. Relative risk of death in patients with a pulmonary complication [On the day of HDU discharge or death, whichever came first, assessed up to 12 weeks after enrollment]

    Risk of death in the group with pulmonary complication divided by the risk of death in parturients without a pulmonary complication

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admitted to the HDU of the PCMH during the study period

  • Verbal informed consent of the patient or his/her formal representative

Exclusion Criteria:
  • Lung ultrasound not feasible, e.g., due to electricity breakdown, or absence of the trained sonographer.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Princess Christian Maternity Hospital Freetown Sierra Leone

Sponsors and Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  • Mahidol Oxford Tropical Medicine Research Unit
  • University of Sierra Leone
  • Doctors with Africa - CUAMM
  • University of Bari

Investigators

  • Study Chair: Marcella Schiavone, MD, PhD, Doctors with Africa - CUAMM
  • Study Chair: Anna de Nicolo, MD, PhD, University of Bari
  • Principal Investigator: Eva Henciles, MD, University of Sierra Leone
  • Principal Investigator: Marcus J Schultz, MD, PhD, University of Amsterdam

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Prof. Dr. Marcus J. Schultz, Professor, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
ClinicalTrials.gov Identifier:
NCT03828630
Other Study ID Numbers:
  • LUSIP
First Posted:
Feb 4, 2019
Last Update Posted:
Apr 25, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 25, 2019